AIM ImmunoTech Other Long Term Liabilities (Quarterly) Insights

AIM ImmunoTech, Inc. (AIM)

1.30 +0.03 (+2.36%) USD | NYAM | Jan 14, 16:00

1.30 0.00 (0.00%) After-Hours: 16:41

View Other Long Term Liabilities (Quarterly) for AIM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Halozyme Therapeutics, Inc.	Upgrade
Agenus, Inc.	Upgrade
Curis, Inc.	Upgrade
Protalix Biotherapeutics, Inc.	--
Armata Pharmaceuticals, Inc.	--